19 commercial payer policies list J2782. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
19 policies from 15 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J2782 |
|---|---|---|
| Izervay (avacincaptad pegol intravitreal injection)Effective 01/01/2024 - 12/31/2024 | Jan 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Izervay (avacincaptad pegol intravitreal solution) | Jan 1, 2026 | Prior auth requiredInferred from policy title |
| Izervay (avacincaptad pegol intravitreal solution)Effective 01/01/2025 - 12/31/2025 | Jan 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J2782 |
|---|---|---|
| Izervay (avancincaptad pegol) (PG168, Ver. 3) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Izervay (avancincaptad pegol) (PG168, Ver. 4) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Izervay (avacincaptad pegol) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Izervay (avacincaptad pegol) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol (e.g., Izervay) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| IZERVAY (AVACINCAPTAD PEGOL) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad Pegol (Izervay) | Oct 31, 2023 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Avacincaptad pegol (Izervay); CP.PHAR.641 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Izervay (avacincaptad pegol) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Ophthalmologic Complement Inhibitors | Dec 1, 2025 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Ophthalmologic Complement Inhibitors | Dec 1, 2025 | Covered |
| Policy | Effective | Status of J2782 |
|---|---|---|
| Ophthalmologic Complement Inhibitors | Dec 1, 2025 | Covered |